Skip to main content
Top
Published in: Rheumatology International 8/2012

01-08-2012 | Original Article

An unusual pediatric case with neurofibromatosis and systemic lupus erythematosus

Authors: Sare Gülfem Akyüz, Aysun Çaltik, Mehmet Bülbül, Özlem Erdoğan, Rahime Renda, Gülay Demircin

Published in: Rheumatology International | Issue 8/2012

Login to get access

Abstract

Neurofibromatosis type 1 (NF1) is a relatively common autosomal dominant disorder affecting mainly ectodermal and mesodermal tissues. It is well known that patients with NF1 have an increased risk of developing benign and malignant tumors, but its association with autoimmune diseases has been rarely reported. Systemic lupus erythematosus is an autoimmune chronic inflammatory disease that has the potential to affect various organ systems. There are four cases with NF1 and SLE reported in the literature up to date. Here, we report a 9-year-old girl presenting with NF1 and SLE, and to our knowledge, this is the first childhood case in the literature.
Literature
1.
go back to reference McKeever K, Shepherd CW, Crawford H, Morrison PJ (2008) An epidemiological, clinical and genetic survey of Neurofibromatosis type 1 in children under sixteen years of age. Ulst Med J 77(3):160–163 McKeever K, Shepherd CW, Crawford H, Morrison PJ (2008) An epidemiological, clinical and genetic survey of Neurofibromatosis type 1 in children under sixteen years of age. Ulst Med J 77(3):160–163
2.
go back to reference Fenichel GM (2001) Neurofibromatosis type 1. In: Clinical pediatric neurology, 4th edn. W.B Saunders, Co., Philadeiphia, pp 134–135 Fenichel GM (2001) Neurofibromatosis type 1. In: Clinical pediatric neurology, 4th edn. W.B Saunders, Co., Philadeiphia, pp 134–135
3.
go back to reference Petty R, Laxer R (2005) Systemic lupus erythematosus. In: Cassidy J, Petty R (eds) Textbook of Pediatric Rheumatology, 5th edn. edn. W.B Saunders, Co., Philadelphia, pp 342–385CrossRef Petty R, Laxer R (2005) Systemic lupus erythematosus. In: Cassidy J, Petty R (eds) Textbook of Pediatric Rheumatology, 5th edn. edn. W.B Saunders, Co., Philadelphia, pp 342–385CrossRef
4.
go back to reference Neurofibromatosis (1998) Conference statement. National Institutes of Health Consensus Development. Arch Neurol 45(5):575–578 Neurofibromatosis (1998) Conference statement. National Institutes of Health Consensus Development. Arch Neurol 45(5):575–578
5.
go back to reference Nanda A (2008) Autoimmune diseases associated with Neurofibromatosis type1. Pediatr Dermatol 25(3):392–393PubMedCrossRef Nanda A (2008) Autoimmune diseases associated with Neurofibromatosis type1. Pediatr Dermatol 25(3):392–393PubMedCrossRef
6.
go back to reference Bitnun S, Bassan H (1975) Neurofibromatosis and SLE. N Eng J Med 292(8):429–430 Bitnun S, Bassan H (1975) Neurofibromatosis and SLE. N Eng J Med 292(8):429–430
7.
go back to reference Riccardi VM (1983) Neurofibromatosis in a patient with systemic lupus erythematosus. Arthritis Rheum 26(4):574PubMedCrossRef Riccardi VM (1983) Neurofibromatosis in a patient with systemic lupus erythematosus. Arthritis Rheum 26(4):574PubMedCrossRef
8.
go back to reference Corominas H, Guardolia JM, Matas L, Vazquez G (2003) Neurofibromatosis and systemic lupus erythematosus. A matter of coincidence? Clin Rheumatol 22:496–497PubMedCrossRef Corominas H, Guardolia JM, Matas L, Vazquez G (2003) Neurofibromatosis and systemic lupus erythematosus. A matter of coincidence? Clin Rheumatol 22:496–497PubMedCrossRef
9.
go back to reference Gerosa PL, Vai C, Bizzozer L, Fontana A, Giussani G, Spinelli M (1993) Immunuological and clinical surveillance in Recklinghausen’s Neurofibromatosis (NF1). Panminerva Med 35:80–85PubMed Gerosa PL, Vai C, Bizzozer L, Fontana A, Giussani G, Spinelli M (1993) Immunuological and clinical surveillance in Recklinghausen’s Neurofibromatosis (NF1). Panminerva Med 35:80–85PubMed
10.
go back to reference Ingram DA, Yang FC, Travers JB, Wenning MJ, Hiatt K, New S, Hood A, Shannon K, Williams DA, Clapp DW (2000) Genetic and biochemical evidence that haploinsufficiency of the NF1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo. J Exp Med 191:181–188PubMedCrossRef Ingram DA, Yang FC, Travers JB, Wenning MJ, Hiatt K, New S, Hood A, Shannon K, Williams DA, Clapp DW (2000) Genetic and biochemical evidence that haploinsufficiency of the NF1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo. J Exp Med 191:181–188PubMedCrossRef
11.
go back to reference Ingram DA, Zhang L, McCarthy J, Wenning MJ, Fisher L, Yang FC, Clapp DW, Kapur R (2002) Lymphoproliferative defects in mice lacking the expression of neurofibromin: functional and biochemical consequences of NF1 deficiency in T-cell development and function. Blood 100:3656–3662PubMedCrossRef Ingram DA, Zhang L, McCarthy J, Wenning MJ, Fisher L, Yang FC, Clapp DW, Kapur R (2002) Lymphoproliferative defects in mice lacking the expression of neurofibromin: functional and biochemical consequences of NF1 deficiency in T-cell development and function. Blood 100:3656–3662PubMedCrossRef
12.
go back to reference Kim TJ, Cariappa A, Cacomini J et al (2002) Defective proliferative responses in B lymphocytes and thymocytes that lack neurofibromin. Mol Immunol 38:701–708PubMedCrossRef Kim TJ, Cariappa A, Cacomini J et al (2002) Defective proliferative responses in B lymphocytes and thymocytes that lack neurofibromin. Mol Immunol 38:701–708PubMedCrossRef
Metadata
Title
An unusual pediatric case with neurofibromatosis and systemic lupus erythematosus
Authors
Sare Gülfem Akyüz
Aysun Çaltik
Mehmet Bülbül
Özlem Erdoğan
Rahime Renda
Gülay Demircin
Publication date
01-08-2012
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 8/2012
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-1966-z

Other articles of this Issue 8/2012

Rheumatology International 8/2012 Go to the issue